创业板指盘初涨幅扩大至1%，上证指数现涨0.15%；大医药概念集体反弹，CRO、创新药、单抗、重组蛋白等概念走强；全市约3800股上涨，1300股下跌，主力资金净流出超20亿元。

Group 1 - The ChiNext Index initially increased by 1%, while the Shanghai Composite Index rose by 0.15% [1] - The large healthcare sector experienced a collective rebound, with strong performance in CRO, innovative drugs, monoclonal antibodies, and recombinant proteins [1] - Approximately 3,800 stocks in the market rose, while 1,300 stocks declined, indicating a net outflow of over 2 billion yuan from major funds [1]